ArticleJournal of translational medicine2014

Targeted cancer immunotherapy via combination of designer bispecific antibody and novel gene-engineered T cells.

Katarzyna Urbanska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.